Asia Pacific Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Asia Pacific Genetic Testing Market Report is Segmented by Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, Other Types), Disease (Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Thalassemia, Rare Diseases, Other Diseases), Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), and Geography (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific). The Market values are Provided (in USD million) for the above segments.

Asia Pacific Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Asia Pacific Genetic Testing Industry Overview

The Asia-Pacific genetic testing market is highly competitive and consists of several major players. In terms of market share, a few major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new ingredients at lower prices. Companies like Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Genomic Health Inc., and Mapmygenome hold the substantial market share in the Asia-Pacific genetic testing market.

Asia Pacific Genetic Testing Market Leaders

  1. Abbott Laboratories

  2. Bio-Rad Laboratories Inc.

  3. Myriad Genetics, Inc.

  4. Genomic Health Inc.

  5. Mapmygenome

  6. *Disclaimer: Major Players sorted in no particular order
Asia-Pacific Gen

Asia Pacific Genetic Testing Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?